	All-Cause Mortality and Cancer Risk Dependent on Blood Se Level and HRG rs10770 Genotypes on a Prospective Cohort of Women with Familial Breast Cancers. Int J Mol Sci Lubi, Stachowski A, Marciniak W, Derkacz R, Kilja, Kilja, Lener MR, Pietrzak S, Cybulski C, D, Huzarski T, Klu, Sulikowski T, Lubi, Scott RJ, Gronwald J. PMID: 41828619 [PubMed - indexed for MEDLINE]
	Heterogeneity of Hormone Receptors and HER2 in Breast Cancer Cutaneous Metastases: An Institutional Experience. Int J Mol Sci Iozzo R, Belcastro E, Fanelli GN, Cinacchi P, Ferrari P, Nicolini A, Scatena C. PMID: 41828595 [PubMed - indexed for MEDLINE]
	Endometrial Dysfunction in Women with Ovarian and Uterine Tumors: What Is Known and What Should Be Learned? Int J Mol Sci Mikhaleva LM, Orazov MR, Dolgov ED, Mikhalev SA, Gioeva ZV, Shakhpazyan NK, Pechnikova VV, Gushchin MY. PMID: 41828593 [PubMed - indexed for MEDLINE]
	The Plasma Glycome Differences Between Women with PCOS and Healthy Controls. Int J Mol Sci Holman M, Li SJ, Ahern MM, Ruhaak LR, Karakas S, Krishnan S. PMID: 41828570 [PubMed - indexed for MEDLINE]
	Evidence for Genotype-Specific Optimal Blood Lead Levels for Cancer Risk: MKI67 rs11016073 and APOB rs1367117 in a Female Prospective Cohort. Int J Mol Sci Lubi, Marciniak W, Derkacz R, Kilja, Kilja, Lener MR, Pietrzak S, Cybulski C, D, Huzarski T, Klu, Sulikowski T, Lubi, Scott RJ, Gronwald J. PMID: 41828541 [PubMed - indexed for MEDLINE]
	Out of Nucleus: Serine 727 Phosphorylation Orchestrates Non-Canonical STAT3 Functions-Relevance to Triple-Negative Breast Cancer. Int J Mol Sci Viavattene D, Marchetti AR, Schael N, Poli V. PMID: 41828466 [PubMed - indexed for MEDLINE]
	Reactive Stroma as a Transversal Prognostic Biomarker for Metastasis in Breast Cancer: Integration of Digital Histopathology and Transcriptomic Profiling. Int J Mol Sci Barrera DP, Núñez MA, Cerda I V, Contreras-Riquelme JS, Henríquez J, Carrasco G, Pereira A, Figueroa V, Toledo V, Chahuan B, Sapunar-Zenteno J, Rodríguez X, Moreno D, Larach JT, Prieto B, García P, Moyano L, Peña J, Cerda-Infante J. PMID: 41828443 [PubMed - indexed for MEDLINE]
	Integrative Meta-Analysis Identifies Epithelial-Mesenchymal Transition Gene Signatures as Key Determinants of Ovarian Cancer Progression and Treatment Outcome. Int J Mol Sci Cassandri M, Pontecorvi P, Cece F, Camero S, Mele G, Romano E, Ceccarelli S, Rizzi R, Marampon F, Angeloni A, Marchese C, Megiorni F. PMID: 41828380 [PubMed - indexed for MEDLINE]
	Applications of Metabolomics to the Clinical Management of Breast Cancer: New Perspectives for Diagnosis, Treatment and Prognosis. Int J Mol Sci Li Y, Mo H. PMID: 41828342 [PubMed - indexed for MEDLINE]
	The Future of Breast Cancer Treatment: From Conventional Wisdom to Nanotechnology-Enabled Precision. Int J Mol Sci Kimta N, Majdalawieh MA, Majdalawieh AF. PMID: 41828336 [PubMed - indexed for MEDLINE]
	Association of Post-Neoadjuvant Chemotherapy MRI and (18)F-FDG PET/CT Findings with Tumor Response and Prognosis in Breast Cancer. Diagnostics (Basel) Çakan Demirel B, Ta, Bayramgil A, Y, Bedir , Erkoç N, Özen A, Tokoçin M, Sünnetçi Ar, Muhammedo, Alt, Bilici A. PMID: 41827989 [PubMed]
	Artificial Intelligence in Triple-Negative Breast Cancer: Applications in Diagnosis, Treatment Response, and Prognosis. Diagnostics (Basel) Fu Z, Huo X, Jing AB, Ma J, Rauch GM. PMID: 41827947 [PubMed]
	Lipid Metabolism and Ferroptosis Resistance in Dormant Breast Cancer Cells: Emerging Therapeutic Vulnerabilities. Diagnostics (Basel) Capella G, Borella F, Battista E, Gallio N, Hotot M, Bertero L, Cassoni P, Castellano I. PMID: 41827943 [PubMed]
	Ensemble Deep Learning-Based High-Precision Framework for Breast Cancer Detection from Histopathological Images. Diagnostics (Basel) Ahmad F, Jaffar A, Latif G, Alghazo J, Bhatti SM. PMID: 41827929 [PubMed]
	Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss. Cancers (Basel) Gaumond SI, Shrestha S, Kamholtz I, Beraja GE, Jimenez JJ. PMID: 41827794 [PubMed]
	From Feasibility to Individualization: Surgery for Breast Cancer Liver and Lung Metastases. Cancers (Basel) Greco M, Cipolla C, Mesi C, Ciminna A, Sambataro D, Scandurra G, Lupo S, Cannata G, Giacomelli L, Gebbia V, Valerio MR. PMID: 41827756 [PubMed]
	Prospective Multimodal Assessment of Radiation-Induced Subclinical Cardiac Changes in Patients with Left Breast Cancer Using Hematologic Biomarkers, Echocardiography, and (18)F-FDG PET/CT: A Pilot Study. Cancers (Basel) Won YK, Lee JW, Lee SM, Yoo ID, Hong SP, Kim ES, Kim B, Kim HD, Kim JE, Oh S, Heo NH, Yoo G, Jo IY. PMID: 41827745 [PubMed]
	DNA Aptamers: Reloaded Tools for Breast Cancer Therapeutics. Cancers (Basel) Carrasco-Maure K, González-Olivares M, Lobos-González L. PMID: 41827702 [PubMed]
	The New Era of Intraperitoneal Carboplatin in Ovarian Cancer: From Biological Rationale to Clinical Implementation. Cancers (Basel) Nagao S, Fujikawa A, Tanaka Y, Tanioka M, Imatani R, Tani Y, Sugihara H, Okamoto K, Matsuoka H, Ida N, Haraga J, Ogawa C, Masuyama H. PMID: 41827699 [PubMed]
	Cannabinoids in Combination with Conventional Breast Cancer Therapies: Mechanistic Insights and the Gap to Clinical Translation. Cancers (Basel) Bizjak A, Poto, . PMID: 41827696 [PubMed]

Articles 1 - 20 / 325898

Page 1 of 16295



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy